Here's a round-up of 2022 FEBS J covers for our community to enjoy as we ease into the new year. We'd like to thank all of our authors, readers and referees for your support in 2022 and look forward to working with you again in 2023!

💥 There are so many excellent reasons to publish with The FEBS Journal! 💥 Have any questions about working with us, just drop us a line 📩 [email protected] Sold and ready to submit to us now - check out our submissions page 👉 buff.ly/40Syk3P

Fumiyo Ikeda Fumiyo Ikeda is Professor at the Ubiquitin Biology Laboratory, Osaka University The University of Osaka 大阪大学. She has served as an editorial board member since 2021. Check out her newly released editor profile interview here 🖇️ buff.ly/40XVwxM

🚨 Issue 4 is out now! 🚨 📸 On the cover: The molecular architecture of the inner blood–retina barrier tight junctions. To learn more, read the State-of-the-Art Review by O’Leary and Campbell in this issue. Read the full issue here 🔗 buff.ly/3EclGTC

The FEBS Journal is seeking an experienced STM journal editor to manage the editorial office and drive forward new initiatives, working closely with the in-house team, Editor-in-Chief Seamus Martin, and Editorial Board. Apply by 14th August 2023 febs.org/news/jobs-posi…

❗ We're hiring - 1 week to go!❗ Are you an experienced STM journal editor who could manage the editorial office & drive forward new initiatives, working closely with the in-house team, Editor-in-Chief Seamus Martin, & Editorial Board? Find out more at: buff.ly/3DHQhYE

cFLIPL acts as a suppressor of TRAIL- and Fas-initiated inflammation by inhibiting assembly of caspase-8/FADD/RIPK1 NF-κB-activating complexes Cell Reports Seamus Martin cell.com/cell-reports/f…

cFLIPL acts as a suppressor of TRAIL- and Fas-initiated inflammation by inhibiting assembly of caspase-8/FADD/RIPK1 NF-κB-activating complexes: Cell Reports cell.com/cell-reports/f…

"Roitt's Essential Immunology" by Seamus Martin is one of the best #immunology books of all time! mostrecommendedbooks.com/lists/best-imm…

Curbing the cell stress response | via European Research Council (ERC) erc.europa.eu/projects-stati…

Our articles report on significant advances in subspecialities of molecular life sciences, including immunology. Recently published: ‘A guide to germ-free and gnotobiotic mouse technology to study #health and #disease’.

🌦️DAMP-ening the joy of #metabolism? The Liu lab Tsinghua University summarise the roles of metabolism-derived #DAMPs in immunological disease: 🌦️buff.ly/3QXIgFZ #Immunology #TissueDamage #Inflammation

🛡️Looking for #WeekendReads to help shield you from all the 🌧️? Peruse our rich archive of #immunology papers! 🛡️buff.ly/3RvHS1N

Celebrating our new position in the Clarivate rankings, with The FEBS Journal moving into Q1 at 58th place (IF 5.5). We publish high-quality research in Biochemistry, Molecular Biology and related areas. Why not submit your paper today! colin adrain The FEBS Journal Cristina Muñoz Pinedo - NON professional account

Prof Hugh Brady comments on the current crisis in 3rd level funding - “funding higher education…is mission-critical for the future competitiveness of the Irish economy “⁦Department of Further and Higher Education⁩ ⁦Patrick O'Donovan⁩ irishtimes.com/life-style/peo…

All of our favourite Nobel Laureates choose The FEBS Journal as a backdrop when being interviewed on TV! Great to meet Venki Ramakrishnan at the recent FEBS Congress in Milan. We are now in Q1 and ahead of all the competition at IF 5.5. Submit your paper today! The FEBS Journal

What a week at the #FEBS2024 Congress. Jam-packed full of amazing science! We had the tough and rewarding job of choosing the daily FEBS Journal poster prize winners and an overall winner. check out this 🧵 to see who won🥁 👀 ! #FEBS #ScienceCongress

Congratulations to Frances Brodsky, who gave an outstanding FEBS Journal Plenary Award lecture at the Milan meeting. Frances has made major contributions to our understanding of the assembly and function of clathrin-coated vesicles and even writes crime novels in her spare time!

The FEBS Journal welcomes submissions in all areas of Cell and Molecular Biology, Biochemistry, Structural Biology, Immunology, and related areas. IF5.5, Q1. If you have not published with us before, why not submit your paper today? The FEBS Journal

FEBS Young Scientists' Forum 2025 in Türkiye features top keynote speakers on cell death, personalized medicine, inflammation & cancer biology: Seamus Martin, Isabel Fabregat, Colinda Scheele and Uğur Sezerman. 🔗 2025.febscongress.org/ysf-speakers 🗓 Apply by 12 Dec 2024! #youngFEBS